Elizabeth M Poole1, Laura D Kubzansky2, Anil K Sood3, Olivia I Okereke4,2, Shelley S Tworoger4,2. 1. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA, 02115, USA. nhlip@channing.harvard.edu. 2. Harvard TH Chan School of Public Health, Boston, MA, USA. 3. MD Anderson Cancer Center, Houston, TX, USA. 4. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA, 02115, USA.
Abstract
PURPOSE: In ovarian cancer patients and mouse models, psychosocial stress is associated with higher circulating markers of angiogenesis and cell migration, impaired immune response, and increasing tumor burden and aggressiveness. In the Nurses' Health Studies (NHS/NHSII), we assessed whether phobic anxiety, a marker of chronic distress, was associated with risk of incident ovarian cancer as well as survival among ovarian cancer patients. METHODS: We used Cox proportional hazards regression to model the relative risks (RRs) and 95 % confidence intervals (CI) of ovarian cancer incidence and survival by categories of the Crown-Crisp phobic anxiety index (CCI). RESULTS: We identified 779 cases of ovarian cancer during 2,497,892 person-years of follow-up. For baseline CCI (NHS: 1988; NHSII: 1993), we observed a statistically nonsignificant increased risk of epithelial ovarian cancer (RR for CCI ≥ 4 vs. 0 or 1: 1.14; 95 % CI 0.96-1.36). However, when we updated CCI (NHS: 2004; NHSII: 2005), the associations were attenuated. Pre-diagnosis CCI was not associated with ovarian cancer survival (RR for ≥4 vs. 0 or 1: 1.00; 95 % CI 0.77-1.31); results were similar for post-diagnosis CCI. CONCLUSIONS: Distress, as measured by phobic anxiety symptoms, was not associated with ovarian cancer risk, although we cannot rule out a modest association. Future research should explore the role of phobic anxiety and other forms of psychological distress and ovarian cancer risk and survival.
PURPOSE: In ovarian cancerpatients and mouse models, psychosocial stress is associated with higher circulating markers of angiogenesis and cell migration, impaired immune response, and increasing tumor burden and aggressiveness. In the Nurses' Health Studies (NHS/NHSII), we assessed whether phobic anxiety, a marker of chronic distress, was associated with risk of incident ovarian cancer as well as survival among ovarian cancerpatients. METHODS: We used Cox proportional hazards regression to model the relative risks (RRs) and 95 % confidence intervals (CI) of ovarian cancer incidence and survival by categories of the Crown-Crisp phobic anxiety index (CCI). RESULTS: We identified 779 cases of ovarian cancer during 2,497,892 person-years of follow-up. For baseline CCI (NHS: 1988; NHSII: 1993), we observed a statistically nonsignificant increased risk of epithelial ovarian cancer (RR for CCI ≥ 4 vs. 0 or 1: 1.14; 95 % CI 0.96-1.36). However, when we updated CCI (NHS: 2004; NHSII: 2005), the associations were attenuated. Pre-diagnosis CCI was not associated with ovarian cancersurvival (RR for ≥4 vs. 0 or 1: 1.00; 95 % CI 0.77-1.31); results were similar for post-diagnosis CCI. CONCLUSIONS: Distress, as measured by phobic anxiety symptoms, was not associated with ovarian cancer risk, although we cannot rule out a modest association. Future research should explore the role of phobic anxiety and other forms of psychological distress and ovarian cancer risk and survival.
Entities:
Keywords:
Anxiety; Cancer; Distress; Oncology; Ovarian cancer
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Tess V Clendenen; Eva Lundin; Anne Zeleniuch-Jacquotte; Karen L Koenig; Franco Berrino; Annekatrin Lukanova; Anna E Lokshin; Annika Idahl; Nina Ohlson; Goran Hallmans; Vittorio Krogh; Sabina Sieri; Paola Muti; Adele Marrangoni; Brian M Nolen; Mengling Liu; Roy E Shore; Alan A Arslan Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-05 Impact factor: 4.254
Authors: Susan K Lutgendorf; Koen DeGeest; Laila Dahmoush; Donna Farley; Frank Penedo; David Bender; Michael Goodheart; Thomas E Buekers; Luis Mendez; Gina Krueger; Lauren Clevenger; David M Lubaroff; Anil K Sood; Steve W Cole Journal: Brain Behav Immun Date: 2010-10-16 Impact factor: 7.217
Authors: Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood Journal: Clin Cancer Res Date: 2008-11-01 Impact factor: 12.531
Authors: Eva Lundin; Laure Dossus; Tess Clendenen; Vittorio Krogh; Kjell Grankvist; Marianne Wulff; Sabina Sieri; Alan A Arslan; Per Lenner; Franco Berrino; Goran Hallmans; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Annekatrin Lukanova Journal: Cancer Causes Control Date: 2009-03-20 Impact factor: 2.506
Authors: Beatriz Martinez-Delgado; Kira Yanowsky; Lucia Inglada-Perez; Miguel de la Hoya; Trinidad Caldes; Ana Vega; Ana Blanco; Teresa Martin; Rogelio Gonzalez-Sarmiento; Maria Blasco; Mercedes Robledo; Miguel Urioste; Honglin Song; Paul Pharoah; Javier Benitez Journal: J Med Genet Date: 2012-04-06 Impact factor: 6.318
Authors: Aoife M Brennan; Jessica L Fargnoli; Catherine J Williams; Tricia Li; Walter Willett; I Kawachi; Lu Qi; Frank B Hu; Christos S Mantzoros Journal: Diabetes Care Date: 2009-02-17 Impact factor: 17.152
Authors: Tianyi Huang; Shelley S Tworoger; Jonathan L Hecht; Megan S Rice; Anil K Sood; Laura D Kubzansky; Elizabeth M Poole Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-09-01 Impact factor: 4.254
Authors: Laura D Kubzansky; Shelley S Tworoger; Andrea L Roberts; Tianyi Huang; Karestan C Koenen; Yongjoo Kim Journal: Cancer Res Date: 2019-09-05 Impact factor: 12.701
Authors: Jennifer A Doherty; Allan Jensen; Linda E Kelemen; Celeste L Pearce; Elizabeth Poole; Joellen M Schildkraut; Kathryn L Terry; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen Journal: J Natl Cancer Inst Date: 2017-10-01 Impact factor: 13.506